The Efficacy and Safety of Mainstream Medications for Patients With cDMARD-Naïve Rheumatoid Arthritis: A Network Meta-Analysis

Background: The mainstream medications for rheumatoid arthritis (RA) include conventional disease-modifying antirheumatic drugs (cDMARDs), which mostly are methotrexate (MTX), and biologic agents such as adalimumab (ADA), certolizumab (CZP), etanercept (ETN), golimumab (GOL), infliximab (IFX), and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Weiyan, Gu, Youyi, Cui, Huanqin, Cao, Yinyin, Wang, Xiaoliang, Yao, Yi, Wang, Mingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871709/
https://www.ncbi.nlm.nih.gov/pubmed/29618976
http://dx.doi.org/10.3389/fphar.2018.00138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871709/
https://www.ncbi.nlm.nih.gov/pubmed/29618976
http://dx.doi.org/10.3389/fphar.2018.00138

Ejemplares similares